4/16/2021 8:27:00 AM
Amgen Completes Acquisition Of Five Prime Therapeutics For $38/Shr Cash
3/30/2021 4:01:16 PM
Amgen To Acquire Rodeo Therapeutics
3/4/2021 8:31:35 AM
Amgen To Acquire Five Prime Therapeutics For $38/Shr Cash, Representing An Equity Value Of $1.9 Bln
3/3/2021 4:03:32 PM
Amgen Inc. (AMGN) Declares $ 1.76 Dividend for Q2 21, Record Date 5/17/2021
3/3/2021 4:03:28 PM
Amgen Declares Q2 Dividend Of $1.76/share, Payable June 8/ Record May 17
2/26/2021 9:04:10 AM
Amgen And AZN: Tezepelumab To Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
2/22/2021 9:02:44 AM
Amgen Announced Submission Of SNDA For Otezla For Adults With Mild-To-Moderate Plaque Psoriasis
2/2/2021 4:01:47 PM
Amgen Q4 GAAP EPS Decrease 3% To $2.76
1/29/2021 4:00:56 PM
Amgen Announces Breakthrough Therapy Designation Granted For Sotorasib In China
1/28/2021 3:59:10 PM
Amgen Reports Results From Phase 2 Cohort Of CodeBreaK 100 Clinical Study Evaluating Investigational Sotorasib